Palo Alto, CA, United States
Palo Alto, CA, United States

Time filter

Source Type

Patent
Anacor Pharmaceuticals Inc. and Glaxosmithkline | Date: 2016-05-23

Norvaline and/or other amino acids that are capable of being acylated onto tRNA^(Leu )by LeuRS, in combination with substituted benzoxaboroles, such as a compound having a structure according to formula III: and methods for decreasing the frequency of resistance and/or reducing the rate of resistance and/or suppressing the emergence of resistance that develops in bacteria exposed to a substituted benzoxaborole or salt thereof by administering a combination of a substituted benzoxaborole such as a compound of formula III or salt thereof and an amino acid or a salt thereof.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-11-18

This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-11-18

This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-11-30

Topical pharmaceutical formulations, and methods of treating inflammatory conditions with these formulations, are disclosed.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-07-08

Compounds and methods of treating anti-inflammatory conditions are disclosed.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-02-17

This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-04-05

This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-08-03

This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-03-11

This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.


Patent
Anacor Pharmaceuticals Inc. | Date: 2016-02-24

This invention relates to boronophthalide compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. Said compounds are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present boronophthalide compounds have physiochemical properties that facilitate penetration of the nail plate.

Loading Anacor Pharmaceuticals Inc. collaborators
Loading Anacor Pharmaceuticals Inc. collaborators